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Abstract
Background: Studies from developed countries have reported on host-related risk factors for
extra-pulmonary tuberculosis (EPTB). However, similar studies from high-burden countries like
Nepal are lacking. Therefore, we carried out this study to compare demographic, life-style and
clinical characteristics between EPTB and PTB patients.
Methods: A retrospective analysis was carried out on 474 Tuberculosis (TB) patients diagnosed
in a tertiary care hospital in western Nepal. Characteristics of demography, life-style and clinical
features were obtained from medical case records. Risk factors for being an EPTB patient relative
to a PTB patient were identified using logistic regression analysis.
Results: The age distribution of the TB patients had a bimodal distribution. The male to female
ratio for PTB was 2.29. EPTB was more common at younger ages (< 25 years) and in females.
Common sites for EPTB were lymph nodes (42.6%) and peritoneum and/or intestines (14.8%). By
logistic regression analysis, age less than 25 years (OR 2.11 95% CI 1.12–3.68) and female gender
(OR 1.69, 95% CI 1.12–2.56) were associated with EPTB. Smoking, use of immunosuppressive
drugs/steroids, diabetes and past history of TB were more likely to be associated with PTB.
Conclusion: Results suggest that younger age and female gender may be independent risk factors
for EPTB in a high-burden country like Nepal. TB control programmes may target young and female
populations for EPTB case-finding. Further studies are necessary in other high-burden countries to
confirm our findings.
Background
Tuberculosis (TB) remains a major global public health
problem [1]. It is estimated that about one-third of the
world's population is infected with mycobacterium tubercu-
losis [2]. After primary infection, TB may reactivate at any-
time and anywhere in the body. Recent studies have
suggested that the sites of extra-pulmonary tuberculosis
(EPTB) may vary according to geographic location and
population [3-6]. Clinical manifestations of TB are varia-
ble and depend on a number of factors that are related to
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understanding of the role of host-related factors responsi-
ble for the occurrence of TB at extra-pulmonary sites is
limited. Some studies have reported that the proportion
of TB that is EPTB is on the rise due to the HIV epidemic
[8,9] and possibly also improvement in diagnostic facili-
ties [10]. Some studies have examined the role of host-
related factors on the risk of development of EPTB. A
study from the USA, reported that women, non-Hispanic
blacks and HIV-infected individuals were at higher risk of
EPTB [3]. Another US study reported that being African
American, HIV-seropositive, less than 18 years of age and
having liver cirrhosis were risk factors for EPTB [11]. A
study from Turkey reported that females had a higher risk
of developing EPTB and the risk of EPTB increased five
years after initial contact [5]. One study reported that
host-related factors for EPTB varied according to geo-
graphic origin and risk factors for EPTB were female gen-
der for individuals of Asian or North African origin, age
for individuals who originated from sub Saharan Africa
and HIV infection for Europeans [12].
Nepal is a high-burden country for TB. About 45% of the
total population is infected with TB and an estimated
20,000 new infectious cases of TB are reported each year
[13]. The estimated annual incidence rate for all types of
TB disease is 187 per 100,000 population. The annual
incidence of new smear-positive TB cases is 83.5 per
100,000 population [14]. Sentinel surveys have reported
that the prevalence of HIV seropositivity among TB
patients has increased from 0.6% in 1995/96 to 2.4% in
2001/02 [13]. Risk factors for EPTB in Nepal may be dif-
ferent to those in low-burden countries, but appropriate
studies to investigate this are lacking. We carried out this
study to identify possible risk factors for EPTB that are dis-
tinctive from risk factors for PTB.
Methods
Study setting
Manipal Teaching Hospital (MTH) is a tertiary care hospi-
tal affiliated to Manipal College of Medical Sciences
(MCOMS) serving the population of Pokhara city and
remote hilly areas of western Nepal. The total population
served by the hospital is about 380000. In March 2003, a
TB treatment (DOTS) clinic was started in MTH, operating
under the National Tuberculosis Program (NTP) of Nepal,
under which the diagnosis of pulmonary TB is followed
by examination of three sputum smears by Ziehl Nielssen
staining for acid fast bacilli [AFB]. Chest radiographs are
also used to support the diagnosis. At MTH, patients diag-
nosed with TB are referred to the DOTS clinic where they
are registered and treated according to NTP guidelines
[13].
Data collection
A total of 526 TB patients registered in the DOTS clinic
from March 31, 2003 to May 30, 2006 were included in
the study. Patients' registration numbers were used to
obtain corresponding files from the medical records
department. From each medical case file, the patient's his-
tory, physical findings, chest radiographs and reports of
laboratory investigations were reviewed to obtain the nec-
essary information about diagnosis of TB. For each
patient, demographic information, lifestyle factors
(smoking habits and alcohol use) and clinical characteris-
tics were recorded. Clinical characteristics included were,
co-morbid conditions (diabetes mellitus, malignancies
etc), treatment history (use of immunosuppressive drugs,
steroids), past history of treatment for TB, history of
known contact with a case of TB and the interval between
contact with a TB patient and onset of the disease.
Classification of PTB and EPTB patients
It is well known that lymph node and pleural involve-
ment in TB is a direct extension of the disease from lung
parenchyma. Therefore, patients with exclusively
intrathoracic involvement (i.e., confined to lung paren-
chyma, pleura, and intrathoracic lymph nodes) were con-
sidered as PTB for the purpose of this analysis. Patients
with extension of disease to organs or tissues outside the
thorax, including those patients who also had pulmonary
involvement, were considered as EPTB in our analysis. We
followed the definitions used in two earlier studies [3,5]
for EPTB and PTB patients.
The following clinical case definitions as recommended
by the World Health Organization [15], after some modi-
fications were used:
Pulmonary tuberculosis
Two or three initial sputum smear examinations positive
for AFB, or one sputum smear positive for AFB plus radio-
graphic abnormalities consistent with active pulmonary
tuberculosis, as determined by a clinician, or one sputum
smear positive for AFB (smear-positive cases). Cases with
three sputum smears negative for AFB but clinical and
radiological features compatible with active tuberculosis
and showing improvement after empirical anti-tuberculo-
sis treatment were considered to be smear-negative cases.
Both smear-positive and smear-negative patients were
treated as pulmonary TB cases for our data analysis.
Extra-pulmonary TB
This included tuberculosis of organs other than the lungs,
such as lymph nodes, abdomen, genitourinary tract, skin,
joints and bones, meninges, etc. Diagnosis of EPTB was
based on fine needle aspiration cytology or biochemical
analyses of cerebrospinal/pleural/ascitic fluid or his-
topathological examination or strong clinical evidencePage 2 of 7
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lowed by a decision of a clinician to treat with a full course
of anti-tuberculosis chemotherapy. Diagnostic procedures
including imageological methods, blood tests or laparot-
omies for excision biopsies, Mantoux tests, and BCG chal-
lenge tests were also used for the diagnosis of EPTB. In all
the cases of EPTB, sputum examinations and chest radio-
graphs were used to investigate the involvement of lung
parenchyma. Our hospital lacks the facilities for culture
and drug susceptibility testing.
Statistical analysis
Data were analyzed using SPSS (Statistical Package for
Social Sciences, version 12). Demographic variables, life-
style factors and clinical characteristics were compared
between EPTB and PTB groups. The Chi square test for cat-
egorical variables and the Mann-Whitney U test for con-
tinuous variables (e.g. age and contact-disease interval)
were used to test for differences between the groups. Epi
Info was used to carry out chi square for trend tests after
stratification by gender. Our main analysis was carried out
using unconditional logistic regression analysis, in which
patients with EPTB were treated as cases and patients with
PTB only were treated as controls. Multi-variate logistic
regression analysis was used to identify the possible risk
factors for EPTB. Odds ratios (OR), 95% confidence inter-
vals (95% CI) and p-values were calculated for each
potential predictor variable.
Results
A total of 526 tuberculosis patients was registered in the
DOTS clinic of MTH during the study period. Fifty two
cases were not included due to incomplete recording of
information (17) and missing medical case files (35).
Four hundred and seventy four cases of TB were included
in the final analysis. Two hundred and thirty patients
(48.5%) were classified as EPTB and 244 (51.5%) as PTB.
Of the 244 cases of PTB, 40 (16.4%) had hilar lymph
node enlargement and/or pleural pathology (unilateral or
bilateral). Of the 230 cases of EPTB, 38 (16.5%) had con-
current PTB. Demographic and descriptive data on the
patients by TB type are shown in Table 1.
Demographic factors
The overall male to female ratio of TB cases was 1.6 (289/
185). For EPTB patients, the male to female ratio was 1.07
(119/111), but 2.29 (170/74) for PTB patients. The differ-
ence was statistically significant (p < 0.001). The median
age of EPTB patients (29.5 years) was lower than that of
PTB patients (47.5 years) (p < 0.001) (Table 1). Since the
gender distributions were also different for PTB and EPTB,
we examined age distributions after stratifying by gender
and TB type. Figure 1 shows the age distributions of EPTB
and PTB for males and females, confirming the tendency
for EPTB to occur at younger ages (< 25 years) in both gen-
ders. The age at incidence of PTB showed evidence of a
bimodal pattern, with peaks at 15–25 years and 60–70
years.
Life-style factors
The proportion of 'ever smoked', (those who were either
currently smoking or ex-smokers) was significantly higher
among PTB patients (51.7%) compared to EPTB patients
(23.5%). Similarly, a significantly higher proportion (i.e.
Table 1: Comparison of pulmonary and extra pulmonary tuberculosis according to demographic, life style and clinical characteristics
Characteristics EPTB (n = 230) PTB (n = 244) p-value
Demographic characteristics
< 25 years 94 (40.9%) 69 (28.3%) < 0.001
25–50 years 86 (37.4%) 63 (25.8%)
> 50 years 50 (21.7%) 112 (45.9%)
Gender (Male/Female) 119/111 170/74 < 0.001
Clinical characteristics
Presence of Diabetes mellitus 2 (0.9%) 16 (6.6%) 0.001
Use of immunosuppressive drugs 3 (1.3%) 20 (8.2%) < 0.001
Past history of pulmonary tuberculosis 10 (4.3%) 37 (15.2%) 0.001
History of contact with TB patients 19 (8.3%) 28 (11.5%) 0.07
Median contact-disease interval in months (quartiles) 24 (6, 54) 24 (6, 84) 0.66
HIV positive patients* Number positive/Number tested 10/48 (20.1%) 6/31 (19.4%) 0.99
Smoking habits
Never smoked 166 (72.2%) 113 (46.3%) < 0.001
Currently smoking 34 (14.8%) 81 (33.2%)
Quit at least 6 months previously 20 (8.7%) 45 (18.5%)
Alcohol use
Never drank alcohol 184 (80%) 160 (65.6%) < 0.001
Currently drinking 24 (10.4%) 49 (20.1%)
Quit at least 6 months previously 12 (5.2%) 30 (12.3%)
* HIV status was not known for all the patients.Page 3 of 7
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alcohol or former alcohol drinkers. (Table 1). In both
sexes higher proportions of PTB patients had 'ever
smoked' as compared to EPTB patients and this difference
was statistically significant (p < 0.05).
Clinical characteristics
As compared to EPTB patients a significantly higher pro-
portion of PTB patients were suffering from diabetes mel-
litus (0.9% vs. 6.6%) (p < 0.001) or had a history of
treatment with immunosuppressive drugs like steroids or
anti-cancer drugs (1.3% vs. 8.2%) (p < 0.001). History of
treatment for pulmonary TB (4.3% vs. 15.2%) in the past
was also more common among PTB patients. The propor-
tion of patients who had a history of contact with a known
case of TB (8.3% vs. 11.5%) was higher among PTB
patients but the duration from contact with a case of TB to
onset of TB was virtually identical among PTB and EPTB
groups. HIV status was known for only 79 out of 474
(16.6%) patients (Table 1), with about 20% positivity in
both PTB and EPTB groups, providing no evidence of a
difference in positivity rates between the two groups (p =
0.99). However, there may have been some selection bias
in terms of who was tested for HIV, masking a difference
in HIV positivity between the groups.
Sites of EPTB
Sites of EPTB according to gender are illustrated in Figure
2. The most common site of EPTB was the lymph nodes
(42.6%) followed by the peritoneum and/or intestines
(14.8%), then bones and/or joints (12.4%). Other sites
were miliary (7.2%), meninges/brain (7.2%), skin
(4.8%), genital (2.9%) and larynx (2.4%). Fifteen EPTB
patients (5.3%) had TB at other sites, namely the middle
ear (4), disseminated (miliary) TB (4), pericardium (3),
and the breast, thyroid, salivary gland and soft tissue (one
each).
Multivariate comparison of EPTB (cases) and PTB patients 
(controls)
The results of the multi-variate logistic regression analyses
are presented in Table 2. The results suggest that younger
age and female gender were associated with EPTB relative
to PTB, whereas diabetes mellitus, use of immunosup-
pressive drugs, past history of PTB and having been a
smoker are more likely to be associated with PTB than
EPTB. The likelihood of development of EPTB was more
than two-fold higher at younger ages (< 25 years) and one
and half times higher among females than in males.
Discussion
Our study reports epidemiology and risk factors of EPTB
from a high-burden country where the prevalence of HIV
is low [13]. To our knowledge no similar study has been
reported from other south Asian countries or other high
TB burden countries. Younger age and female gender were
strongly associated with EPTB, but smoking, diabetes mel-
litus, use of immunosuppressive drugs/steroids, and past
history of pulmonary TB were associated with PTB.
Sites of EPTB
In our study, the lymph nodes were the most common site
of EPTB. Earlier studies have suggested that localization of
EPTB may be variable. In Hong Kong [4], the genitouri-
Distribution of sites of extra-pulmonary tuberculosisFigure 2
Distribution of sites of extra-pulmonary tuberculosis.
Proportional age distribution for EPTB and PTB among the 474 tubercu osis patients stratified by ge erFigure 1
Proportional age distribution for EPTB and PTB among the 
474 tuberculosis patients stratified by gender.Page 4 of 7
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in the USA [3], bones and/or joints were the most com-
mon sites. Results of our study are comparable to two
studies from Turkey [5,6] which reported that lymph
nodes accounted for nearly half the cases of EPTB. In some
studies clinical diagnosis of lymph node tuberculosis has
been strengthened by a positive culture of Mycobacterium
tuberculosis complex [3,6,11]. However, due to lack of
facilities for culture in our setting, lymph node TB is usu-
ally diagnosed by fine needle aspiration cytology and/or
node excision followed by histopathological examination
for granulomatous inflammation with caseous necrosis.
Therefore, we cannot rule out some mis-diagnosis of
lymph node TB.
Risk factors for EPTB
Earlier studies of risk factors for EPTB had a lower propor-
tion of EPTB cases [3,11]. But in our study, proportions of
PTB and EPTB were almost same, possibly because it was
carried out in the main referral centre for the region and
the proportion of EPTB may be higher due to availability
of diagnostic facilities. Pulmonary TB cases are also diag-
nosed at primary health care centres because of the decen-
tralization of diagnostic and treatment facilities under
NTP. This means that they are often never referred to
MTH. Gender differences observed in our study confirm
the findings of previous studies in both developing
[16,17] and developed countries [18,19]. This may be a
consequence of gender differences in both exposures to
TB infection and prevalence of susceptibility risk factors
(e.g., smoking) [16]. Other possible factors accounting for
the difference are stigma associated with having TB and
lack of access to health care, especially for females, in
some developing countries like Nepal [17].
The other main risk factor for EPTB relative to PTB that we
identified was being younger than 25 years. This is con-
sistent with studies from the USA [11] and Europe [12]
which have reported that younger age was an independent
risk factor for EPTB. Other studies from the USA [3] and
Turkey [5], have reported that age was not associated with
EPTB. These inconsistencies could be due to differences in
prevalence of host-related factors or important co-expo-
sures.
In our study, only 4.1% of the patients less than 25 years
of age were "ever smokers" as compared to 74.8% of the
patients who were aged 25 years or more. Proportions of
"ever smokers" differed between males (46.8%) and
females (27.1%). This raises the possibility that the age
and sex differences between PTB cases (in whom smoking
was more common) and EPTB cases could be a result of
confounding by smoking. However, after adjusting for
potential confounding factors (including smoking) by
logistic regression analysis, younger age and female gen-
der remained strongly associated with EPTB. Therefore,
after primary infection in the lungs the probability of reac-
tivation at an extra-pulmonary site may be higher at
younger age. It would be useful to confirm the association
of age and gender with EPTB in other high-burden coun-
tries. Our results suggest that at older ages reactivation of
TB was common in the lungs. This may be due to
decreased local immunity in the lungs in the elderly as a
result of associated life-style factors (smoking) or co-mor-
bid conditions which may predispose to re-activation in
the lungs. A recent study from the UK has reported that co-
morbid conditions like emphysema and bronchitis were
independent risk factors for PTB [20].
In our study, smoking was associated with PTB. This is
consistent with a meta-analysis which reported that smok-
ing is a risk factor for TB infection and for pulmonary TB
disease [21]. Another report has suggested that smoking is
associated with relapse of TB and smokers are less likely to
have isolated extrapulmonary TB [22]. We also found that
past history of TB was associated with PTB, although we
Table 2: Multi-variate logistic regression model determining the 
independent risk factors for development of extra pulmonary 
tuberculosis relative to pulmonary tuberculosis.
Variables P Value Odds ratio 95% CI
Age (Years)
> 50 1 -
25–50 0.61 0.85 (0.46–1.58)
< 25 0.04 1.79 (1.04–3.09)
Gender
Male 0.02 1 -
Female 1.67 (1.08–2.58)
Diabetes mellitus
No 0.01 1 -
Yes 0.14 (0.03–0.65)
Use of immunosuppressive drugs
No 0.01 1 -
Yes 0.14 (0.03–0.62)
Past history of tuberculosis
No 0.001 1 -
Yes 0.25 (0.12–0.55)
Smoking habits*
Never smoked 1 -
Currently smoking 0.001 0.34 (0.18–0.63)
Quit at least 6 months 
previously
0.08 0.45 (0.21–1.09)
Alcohol use*
Never drank alcohol
Currently drinking 0.68 1.21 (0.49–3.01)
Quit at least 6 months 
previously
0.56 1.34 (0.50–3.57)
* A person who quit smoking or drinking alcohol less than 6 months 
ago was coded as current smoker or currently drinking. Information 
about smoking and alcohol intake was not recorded in 15 case files. 
Therefore, 15 files were not included in the final regression analysis 
model.Page 5 of 7
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(relapse) or reinfection [23]. However, evidence suggests
that in high-burden countries reinfection is more com-
mon than relapse [24]. Therefore history of smoking and
contact with a case of TB should arouse a high degree of
suspicion for active TB. Such information would be useful
for screening the patients for TB. Currently there are no
health education campaigns or legislation regarding sales
of cigarettes in Nepal. This is significant public health con-
cern in view of tuberculosis control.
Our results of comparison of EPTB and PTB by logistic
regression analysis suggested that factors like diabetes
mellitus, use of immunosuppressive drugs/steroids and
past history of TB are associated with PTB compared to
EPTB. Our results are consistent with other studies that
have reported an association between diabetes mellitus
and PTB [25,26]. However, study from Turkey [5] exam-
ined the association of diabetes, use of immunosuppres-
sive drugs/steroids and past history of TB with EPTB but
found no association with any of these factors. A study
from the UK [20] reported that use of immunosuppressive
drugs/steroids and co-morbid conditions were associated
with PTB. Therefore it is important to periodically screen
the patients with chronic conditions like diabetes, those
on immunosuppressive drugs/steroids for occurrence of
tuberculosis.
Studies from developed countries have reported an
increasing trend of EPTB among HIV infected persons
[9,10] and HIV infection is associated with EPTB
[3,10,12]. A recent study from a large tertiary hospital in
south India reported that EPTB showed an increasing
trend among HIV infected patients [12]. In Nepal, the
adult HIV/AIDS prevalence is 0.5% [13]. Testing for HIV
infection is carried out based on epidemiological and/or
clinical suspicion and only a fraction of our cases were
tested. Therefore, we did not have enough data to carry
out a useful analysis of the association between HIV infec-
tion and EPTB. We carried out a logistic regression analy-
ses excluding those cases which were HIV-positive. The
results of our main logistic regression analyses did not
change. The reported rate of HIV seropositivity among TB
cases in Nepal was only 2.4% in the year 2001/02 [13].
The current rate may be higher, but probably not high
enough to make a substantive difference to our conclu-
sions. However it is important to screen the HIV/AIDS
patients for TB despite the low incidence of HIV/AIDS in
Nepal. Further studies are required to study the associa-
tion between TB and HIV/AIDS.
Our study had several other limitations. Information
about life style factors was sometimes incompletely
recorded in the files. Therefore, we could not study the
effect of amount and duration of smoking and alcohol use
on EPTB. The PTB and EPTB patients were selected from a
tertiary-care hospital. Hence, the cases we studied may not
be representative of those occurring in the general popu-
lation. Information about nutritional status and micro-
bial factors was not available from the case files in our
setting. A further limitation of the study was that it only
identified factors that differed between PTB and EPTB.
There may be some risk factors common to both forms of
TB that could not be identified by our analysis.
Conclusion
Results of our study suggest that younger age and female
gender may be independent risk factors for EPTB, relative
to PTB in Nepal. Whether this is common to other high-
burden countries also is yet unclear. Further studies in
other high burden countries are needed. In developing
countries, the proportion of EPTB is relatively low and
EPTB is less infectious than PTB. Therefore, EPTB is usu-
ally not prioritized for case finding strategies in TB control
programmes. However, based on our results TB control
programmes might usefully target young and female pop-
ulations for early diagnosis of EPTB to decrease TB mor-
bidity and mortality.
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